Surgery Partners, Inc. (NASDAQ:SGRY) Given Average Recommendation of "Moderate Buy" by Brokerages

Key Points

• Surgery Partners, Inc. has received a consensus recommendation of "Moderate Buy" from ten analysts, with seven endorsing a buy and three suggesting a hold.
• The average one-year price target for the company among analysts is $33.56, showing optimistic expectations for the stock's performance.
• Despite recent earnings that fell short of estimates, Surgery Partners reported an 8.2% increase in revenue year-over-year, totaling $776 million for the quarter.

Shares of Surgery Partners, Inc. (NASDAQ:SGRY - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the ten analysts that are presently covering the stock, MarketBeat reports. Three analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $33.33.

SGRY has been the subject of a number of research analyst reports. Bank of America assumed coverage on shares of Surgery Partners in a report on Monday. They issued a "buy" rating and a $28.00 price target for the company. Benchmark reiterated a "buy" rating and set a $35.00 price objective on shares of Surgery Partners in a research report on Monday, April 21st. Finally, Barclays lowered their price target on Surgery Partners from $25.00 to $24.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 27th.

Surgery Partners Stock Performance

Shares of NASDAQ:SGRY traded up $1.18 on Friday, hitting $22.44. The company's stock had a trading volume of 2,511,884 shares, compared to its average volume of 1,371,877. The company has a market capitalization of $2.88 billion, a price-to-earnings ratio of -14.67 and a beta of 1.90. The company has a debt-to-equity ratio of 1.09, a quick ratio of 1.73 and a current ratio of 1.89. Surgery Partners has a 12 month low of $18.87 and a 12 month high of $33.97. The stock's 50-day moving average is $22.28 and its two-hundred day moving average is $22.84.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last released its quarterly earnings results on Monday, May 12th. The company reported $0.04 EPS for the quarter, missing analysts' consensus estimates of $0.08 by ($0.04). The company had revenue of $776.00 million for the quarter, compared to the consensus estimate of $777.77 million. Surgery Partners had a positive return on equity of 2.41% and a negative net margin of 6.10%. The firm's quarterly revenue was up 8.2% compared to the same quarter last year. During the same quarter last year, the firm posted $0.10 earnings per share. On average, equities research analysts forecast that Surgery Partners will post 0.67 EPS for the current year.

Institutional Investors Weigh In On Surgery Partners

Several institutional investors and hedge funds have recently modified their holdings of SGRY. Point72 Asia Singapore Pte. Ltd. grew its stake in Surgery Partners by 12.1% in the 4th quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,296 shares of the company's stock valued at $91,000 after buying an additional 465 shares during the last quarter. PNC Financial Services Group Inc. raised its holdings in Surgery Partners by 86.4% in the 1st quarter. PNC Financial Services Group Inc. now owns 1,169 shares of the company's stock valued at $28,000 after acquiring an additional 542 shares in the last quarter. AlphaQuest LLC lifted its position in shares of Surgery Partners by 112.0% in the 1st quarter. AlphaQuest LLC now owns 1,058 shares of the company's stock worth $25,000 after acquiring an additional 559 shares during the period. Mackenzie Financial Corp grew its holdings in shares of Surgery Partners by 2.8% during the 4th quarter. Mackenzie Financial Corp now owns 21,974 shares of the company's stock worth $465,000 after purchasing an additional 599 shares in the last quarter. Finally, Wells Fargo & Company MN raised its stake in shares of Surgery Partners by 1.4% in the fourth quarter. Wells Fargo & Company MN now owns 56,931 shares of the company's stock valued at $1,205,000 after purchasing an additional 783 shares in the last quarter.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.